GeNOsys Board of Directors' Chairman and Medical Director Present to New York Investor...

GeNOsys Board of Directors' Chairman and Medical Director Present to New York Investor Funds

PROVO, Utah--(Business Wire)--
GeNOsys (generated nitric oxide systems) Inc. (OTCBB:GNYS), a
medical research and development company specializing in
pharmaceutical, biotechnical and medical gas generating systems,
announces the Company's Board of Directors' Chairman, Mr. Clark Mower,
and Medical Director, Steven Minton, M.D., presented to a group of
investment fund managers and investor relations firms in New York City
on Wednesday, July 30 and Thursday, July 31. Company management
presented information related to GeNOsys' successful research and
development of its patented and patent pending generated Nitric Oxide
technologies.

Clark M. Mower, Chairman of the Board of GeNOsys, said, "We are
extremely excited to avail ourselves for one on one meetings with fund
managers and investor relation firms that have expressed an interest
in our technologies and to better understand where we are heading in
the commercializing of cost effective generated Nitric Oxide. Combined
with solid technologies and a strong public presence, we look forward
to continuing to build shareholder value."

GeNOsys Inc. (generated nitric oxide systems) is a medical
research and development company specializing in pharmaceutical,
biotechnical and medical gas generating systems. Nitric oxide gas is
one of the medical gases that will be generated along with various
combinations of beneficial medical gases suitable for the control of
human disease. GeNOsys management believes it can reduce regulatory
time through the use of strategic partners. Distribution will be
accelerated through the use of already existing distribution networks
that currently sell related respiratory products. For further
information, see the Company's Website at: www.genosysusa.com.

This press release may contain forward-looking statements
including the Company's beliefs about its business prospects and
future results of operations. These statements involve risks and
uncertainties. Among the important additional factors that could cause
actual results to differ materially from those forward-looking
statements are risks associated with the overall economic environment,
changes in anticipated earnings of the company and other factors
detailed in the company's filings with the SEC. In addition, the
factors underlying Company forecasts are dynamic and subject to change
and therefore those forecasts speak only as of the date they are
given. The Company does not undertake to update them; however, it may
choose from time to time to update them and if it should do so, it
will disseminate the updates to the investing public.

GeNOsys Inc.
Michael Dancy, 801-746-3570
medancy@allwest.net

Copyright Business Wire 2008